Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

We critically reviewed host characteristics and hyper-inflammatory response in these two viral infections to have a better insight on the large difference in clinical outcome in persons being infected ...

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Five years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

Leeds moved five points clear at the top of the Championship as they beat Coventry 2-0. Joel Piroe and Jayden Bogle did the damage in the first half to secure the three points at the Coventry ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...